Skip to content
PubMed This is a summary of 43 peer-reviewed journal articles Updated
Clinical Genetics

Obesity due to prohormone convertase I (PCSK1) deficiency: A Patient Guide

At a Glance

PCSK1 deficiency is a rare genetic disorder that may cause severe diarrhea and poor weight gain in infancy, followed by biologically driven, intense hunger and obesity. Children need coordinated nutrition, hormone monitoring, emergency planning, and specialist treatment.

Obesity due to prohormone convertase I (PCSK1) deficiency is an exceptionally rare genetic condition that fundamentally changes how a child’s body communicates with itself. At its core, the condition is a disorder of hormone processing: the body lacks a vital biological “cutter” (the PC1/3 enzyme, encoded by the PCSK1 gene) required to activate several essential hormones. Because these hormones control everything from how we digest food to how we perceive hunger and manage stress, their absence creates a complex, changing medical landscape that evolves as a child grows [1].

For many families, the journey begins with a “biphasic” or two-phase clinical course that can be deeply confusing. In infancy, the lack of active hormones can lead to severe, watery diarrhea and difficulty absorbing nutrients, making it a struggle for the child to gain weight. As the child moves into toddlerhood, the digestive issues often stabilize, but they may be replaced by a new challenge: an intense, insatiable hunger known as hyperphagia. This hunger is not a behavioral issue but a direct result of the brain being unable to receive the “fullness” signals it needs to regulate appetite, which can lead to rapid weight gain [2][3].

Living with this condition requires a focus on four key areas of care. First is the early management of nutrition and hydration to support growth during the digestive phase. Second is the vigilant, individualized monitoring of the endocrine system, as the missing enzyme can cause various hormone deficiencies—such as issues with growth, thyroid function, and the body’s stress response—at different stages of life. Third is the recognition that the intense hunger is biological in nature, requiring specialized medical treatments rather than solely traditional lifestyle changes. Finally, because the condition is so rare, success depends on a dedicated, multidisciplinary care team that can coordinate these different needs [4][5].

What You Should Do Next

  • Confirm the diagnosis: Work with a clinical geneticist to ensure the genetic interpretation is correct.
  • Establish a care team: Identify an expert endocrinology and gastroenterology contact.
  • Create an emergency plan: Obtain a written sick-day and adrenal action plan for your child.
  • Assess treatment options: Discuss whether targeted medications are appropriate for your child’s specific age and genetic profile.

While a diagnosis of PCSK1 deficiency marks the end of a difficult search for answers, it also marks the beginning of a proactive management plan. By understanding the underlying biology, you can better advocate for your child and work with specialists to provide the hormonal and nutritional support they need. This guide is designed to help you navigate each step of that journey, providing the knowledge to empower your family and your medical team [6].

Common questions in this guide

What is PCSK1 deficiency, and how can it affect a child?
PCSK1 deficiency is a rare genetic condition in which the body lacks an enzyme needed to activate several hormones. It can cause severe diarrhea and poor nutrient absorption in infancy, followed later by intense hunger, rapid weight gain, and problems involving growth, thyroid function, or the stress response.
Why can a child with PCSK1 deficiency develop diarrhea first and intense hunger later?
The condition may follow a two-phase pattern as different hormone effects become more apparent during growth. Digestive problems and poor weight gain may occur in infancy, while later the brain may not receive normal fullness signals, leading to biologically driven hyperphagia and obesity.
Which specialists should care for a child with PCSK1 deficiency?
Care commonly involves a clinical geneticist, an endocrinologist, and a gastroenterologist working as a multidisciplinary team. These specialists can coordinate genetic interpretation, digestive and nutritional support, hormone monitoring, and treatment planning.
What should families do after a child is diagnosed with PCSK1 deficiency?
Families should confirm the genetic interpretation, establish specialist care, and address nutrition and hydration needs. They should also ask for a written sick-day and adrenal action plan and discuss whether targeted medications are appropriate for the child’s age and genetic profile.
Is the intense hunger caused by PCSK1 deficiency a behavior problem?
No. The intense hunger, called hyperphagia, is biologically driven because the brain may not receive the fullness signals needed to regulate appetite. Families can ask the care team for help explaining this to schools and other caregivers.

Get notified when new evidence is published on Obesity due to prohormone convertase I deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    PCSK1 Variants and Human Obesity.

    Ramos-Molina B, Martin MG, Lindberg I

    Progress in molecular biology and translational science 2016; (140()):47-74.

    PMID: 27288825
  2. 2

    A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings.

    Duclaux-Loras R, Bourgeois P, Lavrut PM, et al.

    Clinics and research in hepatology and gastroenterology 2021; (45(6)):101640 doi:10.1016/j.clinre.2021.101640.

    PMID: 33662777
  3. 3

    Novel Homozygous Inactivating Mutation in the PCSK1 Gene in an Infant with Congenital Malabsorptive Diarrhea.

    Aerts L, Terry NA, Sainath NN, et al.

    Genes 2021; (12(5)) doi:10.3390/genes12050710.

    PMID: 34068683
  4. 4

    A New Case of PCSK1 Pathogenic Variant With Congenital Proprotein Convertase 1/3 Deficiency and Literature Review.

    Pépin L, Colin E, Tessarech M, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(4)):985-993 doi:10.1210/jc.2018-01854.

    PMID: 30383237
  5. 5

    The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.

    Yeo GSH, Chao DHM, Siegert AM, et al.

    Molecular metabolism 2021; (48()):101206 doi:10.1016/j.molmet.2021.101206.

    PMID: 33684608
  6. 6

    Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial.

    Argente J, Verge CF, Okorie U, et al.

    The lancet. Diabetes & endocrinology 2025; (13(1)):29-37 doi:10.1016/S2213-8587(24)00273-0.

    PMID: 39549719

This page is for informational purposes only and does not constitute medical advice. Your child’s geneticist, endocrinologist, and gastroenterologist should interpret the diagnosis and guide individualized nutrition, hormone, and medication decisions.